Variant report
Variant | nsv822816 |
---|---|
Chromosome Location | chr4:165868349-165869792 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr4:165869324-165869372 | MCF-7 | breast: | n/a | n/a |
2 | MYC | chr4:165869600-165869631 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | POLR2A | chr4:165869313-165869341 | MCF-7 | breast: | n/a | n/a |
4 | POLR2A | chr4:165869111-165869148 | ProgFib | skin: | n/a | n/a |
5 | POLR2A | chr4:165869143-165869152 | MCF-7 | breast: | n/a | n/a |
6 | POLR2A | chr4:165869127-165869138 | MCF-7 | breast: | n/a | n/a |
7 | USF2 | chr4:165869452-165869484 | GM12878 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C4orf39-3 | chr4:165869231-165869699 | NONHSAT099093 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236941 | TF binding region |
ENSG00000199347 | chromatin interactions |
ENSG00000250486 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148796053 | chr4:165868356-165868357 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs56126121 | chr4:165868363-165868364 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs190217173 | chr4:165868371-165868372 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs544749172 | chr4:165868393-165868394 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs566544956 | chr4:165868424-165868425 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs77113509 | chr4:165868437-165868438 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs397879249 | chr4:165868449-165868450 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs541796911 | chr4:165868458-165868459 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs183112018 | chr4:165868460-165868461 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs143591131 | chr4:165868466-165868467 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs567748162 | chr4:165868467-165868468 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs538098924 | chr4:165868501-165868502 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs112370342 | chr4:165868531-165868532 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs543050465 | chr4:165868557-165868558 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs571700374 | chr4:165868573-165868574 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs377438808 | chr4:165868622-165868623 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs187608551 | chr4:165868637-165868638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554469328 | chr4:165868638-165868639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572909452 | chr4:165868647-165868648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113549251 | chr4:165868655-165868656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548026403 | chr4:165868721-165868722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563390118 | chr4:165868743-165868744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540211557 | chr4:165868750-165868751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192618298 | chr4:165868788-165868789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185618343 | chr4:165868790-165868791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs56410348 | chr4:165868812-165868813 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs557510615 | chr4:165868825-165868826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577548501 | chr4:165868862-165868863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13116412 | chr4:165868976-165868977 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs200781123 | chr4:165868984-165868985 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs374717212 | chr4:165868985-165868986 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs532929404 | chr4:165868991-165868992 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs544937212 | chr4:165869025-165869026 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs386681635 | chr4:165869027-165869028 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs79370093 | chr4:165869028-165869029 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs527728592 | chr4:165869031-165869032 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs548958606 | chr4:165869042-165869043 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs567515495 | chr4:165869045-165869046 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs531833389 | chr4:165869046-165869047 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs188965837 | chr4:165869047-165869048 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs13143461 | chr4:165869055-165869056 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs13116089 | chr4:165869083-165869084 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs4417925 | chr4:165869110-165869111 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs571825618 | chr4:165869140-165869141 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs539217588 | chr4:165869156-165869157 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs112586990 | chr4:165869179-165869180 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs140343523 | chr4:165869190-165869191 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs200334899 | chr4:165869284-165869285 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs533811860 | chr4:165869300-165869301 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs7440598 | chr4:165869332-165869333 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
intellectual deficit | 22127048 | CNVD |
abnormal development | 18461090 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:165859200-165869200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr4:165864600-165869200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr4:165864800-165869000 | Weak transcription | Fetal Muscle Leg | muscle |
4 | chr4:165864800-165869200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr4:165866600-165868400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr4:165866800-165869200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr4:165866800-165870800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr4:165867000-165870800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr4:165867600-165869400 | Enhancers | GM12878-XiMat | blood |
10 | chr4:165869000-165869600 | Enhancers | Fetal Muscle Trunk | muscle |
11 | chr4:165869000-165871200 | Enhancers | Fetal Muscle Leg | muscle |
12 | chr4:165869200-165869400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr4:165869200-165869400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr4:165869200-165869600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr4:165869200-165869600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr4:165869200-165869600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr4:165869400-165870200 | Weak transcription | GM12878-XiMat | blood |
18 | chr4:165869600-165870200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr4:165869600-165870800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |